PLX = loser stock just like Obama is a loser, lying US President and Hillary if elected will be the same. Sell all 3 losers.
Sell PLX before company goes bankrupt. Get Out now.
I told all you folks PLX stock was used as a ATM by the incompetent top management. I bet you wish you listened to me now. Vote the all out on next proxy and vote democrats all out in Nov. 2016 elections......win-win again.
PLX was worst stock the past 8 years like Obama has been worst President in US History.
Stunned by Trump?s dominance, Hillary now taking 20 Mg. of Prozac daily for depression. Sorry Liberals but Hillary will need more than Prozac when she has to debate Trump. Buy Lilly or Pfizer not #$%$ like PLX run by greedy jewish morons.
FOLKS SELL PLX and Most Democrats are embarrassed by the lies, incompetence and utter failure of Obama & Hillary Clinton. Many will vote for Trump in Nov. I plan to vote for Trump or Cruz as a Reagan democrat.
Get out of the garbage. Stocks below $8 Bucks are #$%$.
Buy #$%$ stock like PLX run by greedy incompetent morons these is what happens and when you elect #$%$ like Obama look what he does to the USA and World.......makes a mess for the next President to cleanup.
Short ratio is circa 22. Ie, 22 days are neded to cover. If good news pop in the shorts will be burned.
Here is a new Tip::: Pleas vote for all GOP ticket come Nov. 2016 or the USA will go down the toilet like PLX stock price did the past 2 years. Always listen to your Doctor not corrupt lying folks in government or PLX overpaid top management.
Sentiment: Strong Sell
All these biotech executives get HIGHLY paid to run money losing companies and probably the majority will fail. I think only RDNT is the only profitable company in your list and it is NOT a biotech. What a cushy job it is to be a biotech executive. Most of the time spent is waiting for CLINICAL TRIALS trials which take YEARS to do and FAIL most of the time.
I think XOMA has failed many late stage phase 3 clinical trials over the last 30 years. XOMA's balance sheet has over $1 billion in losses accumulated of investor's money. Amazing that XOMA has wasted so much investor's money over 30 years. I think XOMA has finally decided to liquidate company.
The high executive salaries is due to the fact that board of directors use comparable PUBLIC companies to determine executive salaries instead of performance based compensation. Biotech executives leach off investor money and drain cash from a company.